Commerce Bank’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
4,541
-36
-0.8% -$6.41K ﹤0.01% 740
2026
Q1
$790K Buy
4,577
+26
+0.6% +$4.82K ﹤0.01% 794
2025
Q4
$908K Sell
4,551
-607
-12% -$110K 0.01% 695
2025
Q3
$807K Sell
5,158
-8
-0.2% -$1.27K ﹤0.01% 727
2025
Q2
$784K Sell
5,166
-60
-1% -$8K ﹤0.01% 708
2025
Q1
$787K Sell
5,226
-38
-0.7% -$6.37K 0.01% 693
2024
Q4
$972K Sell
5,264
-133
-2% -$25.6K 0.01% 642
2024
Q3
$1.06M Sell
5,397
-107
-2% -$22.2K 0.01% 631
2024
Q2
$1.14M Sell
5,504
-141
-2% -$31.9K 0.01% 591
2024
Q1
$1.53M Sell
5,645
-216
-4% -$51.6K 0.01% 526
2023
Q4
$1.39M Sell
5,861
-78
-1% -$15.3K 0.01% 533
2023
Q3
$1.16M Buy
5,939
+135
+2% +$27.7K 0.01% 548
2023
Q2
$1.22M Sell
5,804
-44
-0.8% -$8.75K 0.01% 541
2023
Q1
$1.18M Buy
5,848
+146
+3% +$33.1K 0.01% 532
2022
Q4
$1.24M Sell
5,702
-5
-0.1% -$1.09K 0.01% 519
2022
Q3
$1.12M Sell
5,707
-421
-7% -$90.9K 0.01% 523
2022
Q2
$1.31M Buy
6,128
+604
+11% +$148K 0.01% 515
2022
Q1
$1.57M Sell
5,524
-789
-12% -$243K 0.01% 507
2021
Q4
$2.38M Sell
6,313
-356
-5% -$138K 0.02% 441
2021
Q3
$2.75M Sell
6,669
-119
-2% -$49.4K 0.02% 418
2021
Q2
$2.51M Buy
6,788
+85
+1% +$28.4K 0.02% 421
2021
Q1
$1.94M Sell
6,703
-460
-6% -$128K 0.01% 447
2020
Q4
$1.79M Sell
7,163
-60
-0.8% -$14.3K 0.01% 443
2020
Q3
$1.64M Buy
7,223
+9
+0.1% +$1.87K 0.01% 431
2020
Q2
$1.26M Sell
7,214
-2
-0% -$319 0.01% 469
2020
Q1
$911K Buy
7,216
+96
+1% +$14.4K 0.01% 457
2019
Q4
$1.09M Sell
7,120
-465
-6% -$64.4K 0.01% 464
2019
Q3
$1M Buy
7,585
+71
+0.9% +$9.52K 0.01% 476
2019
Q2
$1.07M Sell
7,514
-1,187
-14% -$161K 0.01% 415
2019
Q1
$1.26M Sell
8,701
-110
-1% -$14.5K 0.02% 370
2018
Q4
$997K Sell
8,811
-1,221
-12% -$153K 0.01% 390
2018
Q3
$1.35M Sell
10,032
-8,690
-46% -$1.07M 0.02% 368
2018
Q2
$2.1M Sell
18,722
-762
-4% -$82.4K 0.03% 290
2018
Q1
$2.08M Buy
19,484
+3,960
+26% +$427K 0.03% 292
2017
Q4
$1.7M Buy
15,524
+8,966
+137% +$976K 0.02% 322
2017
Q3
$709K Hold
6,558
0.01% 461
2017
Q2
$663K Buy
6,558
+275
+4% +$25.3K 0.01% 467
2017
Q1
$565K Buy
6,283
+2,120
+51% +$180K 0.01% 492
2016
Q4
$317K Sell
4,163
-1,078
-21% -$81.9K ﹤0.01% 633
2016
Q3
$437K Hold
5,241
0.01% 543
2016
Q2
$432K Sell
5,241
-100
-2% -$8.24K 0.01% 542
2016
Q1
$405K Hold
5,341
0.01% 558
2015
Q4
$430K Buy
5,341
+941
+21% +$67.9K 0.01% 529
2015
Q3
$280K Sell
4,400
-300
-6% -$21.5K ﹤0.01% 659
2015
Q2
$331K Sell
4,700
-25
-0.5% -$1.85K 0.01% 643
2015
Q1
$375K Sell
4,725
-338
-7% -$24.9K 0.01% 604
2014
Q4
$322K Buy
5,063
+338
+7% +$21.2K 0.01% 659
2014
Q3
$283K Hold
4,725
﹤0.01% 670
2014
Q2
$253K Hold
4,725
﹤0.01% 699
2014
Q1
$286K Hold
4,725
﹤0.01% 650
2013
Q4
$251K Hold
4,725
﹤0.01% 679
2013
Q3
$218K Sell
4,725
-175
-4% -$8.03K ﹤0.01% 698
2013
Q2
$202K Buy
+4,900
New +$210K ﹤0.01% 716

Other funds holding CRL

Commerce Bank's CRL Position: Q2 2026 in Review

Commerce Bank reduced its Charles River Laboratories (CRL) stake by 0.79% in Q2 2026, selling an estimated $6.41K and leaving 4,541 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Commerce Bank first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.75M in Q3 2021. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Commerce Bank held 4,541 shares of Charles River Laboratories worth $1.03M as of Q2 2026.
  • Commerce Bank sold 36 Charles River Laboratories shares in Q2 2026, an estimated $6.41K.
  • Charles River Laboratories made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #740 holding.
  • Commerce Bank first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Commerce Bank's Charles River Laboratories position peaked at $2.75M in Q3 2021.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.